Nextech Venture logo

Nextech Venture

Europe, Zurich, Switzerland, Zürich

Description

Nextech Venture manages, and advises two investment funds with a focus on healthcare.

Investor Profile

Nextech Venture has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series D rounds (top funding stages).
  • Majority of deals are located in United States, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Manufacturing.

Stage Focus

  • Series A (67%)
  • Series D (33%)

Country Focus

  • United States (67%)
  • Germany (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Manufacturing
  • Life Science
  • Therapeutics
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nextech Venture frequently co-invest with?

Eli Lilly & Company Foundation
North America, Indiana, United States, Indianapolis
Co-Investments: 1
OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Alexandria Real Estate Equities
North America, California, United States, Pasadena
Co-Investments: 1
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Mitsubishi UFJ
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
CIDC Consultants
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Arcus Ventures
North America, New York, United States, New York
Co-Investments: 2
Red Abbey Venture Partners
North America, Maryland, United States, Baltimore
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
II
North America, California, United States, Irvine
Co-Investments: 1

What are some of recent deals done by Nextech Venture?

Palyon Medical

New York, New York, United States

Palyon Medical Corporation, a medical device company, develops technologies for the treatment of neurological diseases.

Health CareHealth DiagnosticsMedical Device
Series AAug 10, 2009
Amount Raised: $24,000,000
MacroGenics

Rockville, Maryland, United States

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

BiotechnologyHealth CareManufacturing
Series DOct 23, 2008
Amount Raised: $25,000,000
ImVisioN Therapeutics

Hanover, Niedersachsen, Germany

ImVisioN Therapeutics is a proprietary technology for the delivery of immunotherapy in the treatment of allergies.

BiotechnologyLife ScienceTherapeutics
Series ASep 10, 2008
Amount Raised: $4,071,930